NCT06950697View on ClinicalTrials.gov

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

RecruitingOBSERVATIONAL
Enrollment

2,400

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 1, 2027

Conditions
Lung CancerVenous ThromboembolismArterial Thromboembolism
Trial Locations (5)

Unknown

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

The Fourth Hospital of Inner Mongolia Autonomous Region, Hohhot

RECRUITING

Beijing Chaoyang Hospital, Capital Medical University, Beijing

RECRUITING

Beijing Luhe Hospital, Capital Medical University, Beijing

RECRUITING

China-japan Friendship Hospital, Beijing

All Listed Sponsors
collaborator

Capital Medical University

OTHER

collaborator

China-Japan Friendship Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

The Fourth Hospital of Inner Mongolia Autonomous Region

UNKNOWN

lead

Beijing Chao Yang Hospital

OTHER